Inotai András, Németh Bertalan
a Syreon Research Institute , Budapest , Hungary.
b Department of Health Policy and Health Economics , Eötvös Loránd University (ELTE) , Budapest , Hungary.
Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):379-381. doi: 10.1080/14737167.2019.1626720. Epub 2019 Jun 5.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) organized its first Central Eastern European regional meeting in 2019 in Warsaw, Poland. The scientific program of the two-day conference covered a broad range of topics presented from the perspective of the region. Specifically, the focus was on cross-country collaboration within different steps of health technology assessment (HTA) and the need for local HTA adaptations in decision-making. Attended by approximately 200 delegates from many countries and by several high level ISPOR leaders, the conference provided a valuable opportunity to exchange knowledge and strengthen the scientific network among experts from different stakeholder groups on issues specific to the region.
国际药物经济学与成果研究协会(ISPOR)于2019年在波兰华沙举办了其首届中东欧地区会议。为期两天的会议科学议程涵盖了从该地区视角呈现的广泛主题。具体而言,重点是卫生技术评估(HTA)不同阶段的跨国合作以及决策中本地HTA调整的必要性。来自许多国家的约200名代表以及ISPOR的几位高层领导人出席了会议,此次会议为不同利益相关者群体的专家就该地区特定问题交流知识和加强科学网络提供了宝贵机会。